Clinical Trial

Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

Study acronym: TIME-MINOR
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To verify the efficacy and safety of intravenous tenecteplase (TNK) in patients with disabling minor stroke and large vessel occlusion (LVO) within a 4.5-24 hour time window.
Trial Details
NCT Number NCT07476898
Lead Sponsor First Hospital of China Medical University
Conditions Stroke
Enrollment 864 participants
Start Date 2026-03-01
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-17